metaraminol has been researched along with Bipolar Disorder in 2 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
Bipolar Disorder: A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murphy, DL | 2 |
| Colburn, RW | 2 |
| Davis, JM | 2 |
| Bunney, WE | 2 |
2 other studies available for metaraminol and Bipolar Disorder
| Article | Year |
|---|---|
Stimulation by lithium of monoamine uptake in human platelets.
Topics: Bipolar Disorder; Blood Platelets; Carbon Isotopes; Humans; Imipramine; Lithium; Metaraminol; Seroto | 1969 |
Imipramine and lithium effects of biogenic amine transport in depressed and manic-depressed patients.
Topics: Animals; Biological Transport; Bipolar Disorder; Blood Platelets; Brain; Cell Membrane; Depression; | 1970 |